CT
City Therapeutics
United States · Biotech · Healthtech · Enterprise software
City Therapeutics develops RNA-interference therapeutics and an engineering platform across disease areas.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $99.5M | AN Ventures — Role not disclosedARCH Venture Partners — Role not disclosedCasdin Capital — Role not disclosedFidelity Management & Research Company — Role not disclosedInvus — Role not disclosedNYBC Ventures — Role not disclosedRegeneron Ventures — Role not disclosedRock Springs Capital — Role not disclosedSlate Path Capital — Role not disclosedSofinnova Investments — Role not disclosedViking Global Investors — Role not disclosed |